Table 5.
Questions | Small to moderate prostate volumes (<80 ml) (n=11) | Moderate to large prostate volumes (80–150 ml) (n=5) | Large prostate volumes (>150 ml) (n=3) | ||
---|---|---|---|---|---|
| |||||
n (%) | n (%) | n (%) | |||
1 | The amount of information provided was: | Much less than wanted | – | – | – |
A little less than wanted | – | 2 (40.0%) | 1 (33.33%) | ||
About right | 11 (100%) | 3 (60.0%) | 2 (66.67%) | ||
A little more than wanted | – | – | – | ||
Much more than wanted | – | – | – | ||
2 | The length of the PtDA was: | Too short | – | – | 1 (33.33%) |
Just right | 9 (81.82%) | 5 (100.0%) | 2 (66.67%) | ||
Too long | 2 (18.18%) | – | – | ||
3 | The language used was easy to follow: | Strongly disagree | – | – | – |
Disagree | – | – | – | ||
Neutral | – | – | – | ||
Agree | 3 (27.27%) | 1 (20.0%) | 2 (66.67%) | ||
Strongly agree | 8 (72.73%) | 4 (80.0%) | 1 (33.33%) | ||
4 | The outcomes reported were easy to follow: | Strongly disagree | – | – | – |
Disagree | – | – | – | ||
Neutral | 2 (18.18%) | – | – | ||
Agree | 6 (54.55%) | 3 (60.0%) | 2 (66.67%) | ||
Strongly agree | 3 (27.27%) | 2 (40.0%) | 1 (33.33%) | ||
| |||||
Section for all prostate volumes | |||||
| |||||
Questions | n (%) | n (%) | n (%) | ||
| |||||
5 | This decision aid would have been helpful during my treatment decision-making: | Strongly disagree | – | – | – |
Disagree | – | – | – | ||
Neutral | 1 (9.09%) | – | 1 (33.33%) | ||
Agree | 4 (36.37%) | 4 (80.0%) | — | ||
Strongly agree | 6 (54.54%) | 1 (20.0%) | 2 (66.67%) | ||
6 | I would recommend this decision aid for new patients with BPH: | Strongly disagree | – | – | – |
Disagree | – | – | – | ||
Neutral | – | – | – | ||
Agree | 3 (27.27%) | 2 (40.0%) | – | ||
Strongly agree | 8 (72.73%) | 3 (60.0%) | 3 (100%) | ||
7 | I am satisfied with the overall quality of this PtDA: | Strongly disagree | – | – | – |
Disagree | – | – | – | ||
Neutral | – | – | – | ||
Agree | 3 (27.27%) | 2 (40.0%) | 2 (66.67%) | ||
Strongly agree | 8 (72.73%) | 3 (60.0%) | 1 (33.33%) |
BPH: benign prostatic hyperplasia; PtDA: patient decision aid.